Contact Us

Advisory Board

Comprised of both anterior and posterior experts, our Industry, Medical and Scientific Advisory Board brings together leaders across ophthalmology to shape Lexitas’ strategic vision and drive growth and innovation for our customers and partners.

Meet Our Industry, Medical and Scientific Advisory Board

Carol Aune, OD

Joseph Boorady, OD

Robert Dempsey

David Eichenbaum, MD

Sherif El-Harazi, MD

Claire Gelfman, PhD

Roger Goldberg, MD

Preeya Gupta, MD

Houman Hemmati, MD

Paul Karpecki, OD

Arshad Khanani, MD

Lejla Vajzovic, MD

Hear from Ad Board Members

David Eichenbaum, MD
Lexitas has brought together a unique group of clinical trial stakeholders to form its advisory board—demonstrating a genuine commitment to listening, learning, and serving the needs of the ophthalmic clinical trial community. Their eagerness to tailor their approach to the evolving landscape of ophthalmology research, combined with a clear willingness to engage with and learn from this group of experienced advisors, truly sets them apart.
David Eichenbaum, MD
Lexitas has brought together a unique group of clinical trial stakeholders to form its advisory board—demonstrating a genuine commitment to listening, learning, and serving the needs of the ophthalmic clinical trial community. Their eagerness to tailor their approach to the evolving landscape of ophthalmology research, combined with a clear willingness to engage with and learn from this group of experienced advisors, truly sets them apart.
David Eichenbaum, MD
Lexitas has brought together a unique group of clinical trial stakeholders to form its advisory board—demonstrating a genuine commitment to listening, learning, and serving the needs of the ophthalmic clinical trial community. Their eagerness to tailor their approach to the evolving landscape of ophthalmology research, combined with a clear willingness to engage with and learn from this group of experienced advisors, truly sets them apart.